Eva Morava-kozicz
Clinical trials sponsored by Eva Morava-kozicz, explained in plain language.
-
Sugar therapy faces its biggest test yet for rare disease
Disease control Not yet recruitingThis study tests if a sugar called AVTX-801 (D-galactose) can help control symptoms of a rare genetic disease called PGM1-CDG. About 8 adults who already take D-galactose will be randomly assigned to get the study drug or a placebo, then switch. The goal is to see if it reduces e…
Phase: PHASE2 • Sponsor: Eva Morava-Kozicz • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Could a common supplement help a rare disease? new study begins safety check
Knowledge-focused Not yet recruitingThis early-stage study will test the safety of the dietary supplement NMN in 8 people aged 4 and older who have a rare genetic condition called DHDDS-CDG. The main goal is to see if NMN is safe and tolerable, and to gather information that may help doctors decide whether to recom…
Phase: PHASE1 • Sponsor: Eva Morava-Kozicz • Aim: Knowledge-focused
Last updated May 18, 2026 12:04 UTC